CSIMarket
 
Immunogen inc   (IMGN)
Other Ticker:  
 
 

Immunogen Inc Income Statement Quarterly

IMGN


Select the Financial Report:   Period:   Fiscal Year:

INCOME STATEMENT
(Quarterly GAAP In millions $)

(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Revenue From Contract With Customer Including Assessed Tax 113.43 83.15 49.87 15.38
License And Milestone Fees Revenue - - - -
Research And Development Revenue - - - -
License And Milestone Fees - - - -
Non Cash Royalty Revenue Related To Sale Of Future Royalties - - - -
Clinical Material Revenue - - - -
Total Revenue 113.43 83.15 49.87 41.17 15.38
Cost of Revenues - - - - -
Gross Profit 113.43 83.15 49.87 41.17 15.38
Selling, Administration, Marketing 37.74 36.36 40.02 42.07 33.62
Depriciation & Amortization - - - - -
Research and Development Expense 47.57 50.08 51.62 58.49 59.18
Restructuring Charges - - - - -
Other operatinig exp. /-income - 0.91 0.63 0.18 -
Unusual Expense /-Income - - - - -
Cost Of Goods And Services Sold Operating 2.16 - - - -
Total operating costs including COS 87.47 87.34 92.26 100.73 92.80
Operating income/-loss 25.96 -4.19 -42.39 -59.56 -77.43
Other Deductions / - Income
Interest expense - - - - -
Interest income - - - - -
Net interest expense/-income - - - - -
Investment Income, Net - - - - -
Foreign Currency Transaction (Gain) Loss - - - - -
Allowances, Health Care Trust Fund And Other - - - - -
Unexpected (Gain) Loss - - - - -
Other loss/ -income -3.63 -0.82 -1.38 -1.77 -0.54
Non Cash Interest Expense From Sale Of Future Royalties - - - - 0.87
Total costs & expenses 83.84 86.52 90.88 98.96 93.13
Income /-loss before income taxes 29.58 -3.37 -41.01 -57.79 -77.76
Income taxes expenses/-benefit -1.17 0.88 - 1.22 -
Income after income taxes 30.75 -4.25 -41.01 -59.01 -77.76
Net income/-loss of other equity - - - 0.00 -
Income/-loss from cont. Ops. 30.75 -4.25 -41.01 -59.01 -77.76
Accounting change - - - - -
Discontinued operations - - - - -
Extraordinary items - - - - -
Net Income/-loss 30.75 -4.25 -41.01 -59.01 -77.76
Noncontrolling interests - - - - -
Prefered dividends - - - - -
Other - - - - -
Income/-loss to shareholder 30.75 -4.25 -41.01 -59.01 -77.76
EBIT 29.58 -3.37 -41.01 -57.79 -77.76
EBITD 30.01 -2.94 -40.57 -57.36 -77.33
EBITDA 30.01 -2.94 -40.57 -57.36 -77.33


Per Share (GAAP Quarterly, in $) (Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Basic EPS (excl. extra items) 0.10 -0.02 -0.16 -0.23 -0.31
   Extraordinary items 0.00 0.00 0.00 0.00 0.00
Basic Net EPS 0.10 -0.02 -0.16 -0.23 -0.31
Basic shares outstanding (Mill. of Units) 273.34 263.45 258.85 254.41 253.51
   EPS other shares - - - - -
Diluted Net EPS 0.10 -0.02 -0.16 -0.19 -0.31
Diluted average shares (Mill. of Units) 287.59 263.45 258.85 253.33 253.51
Dividend per share - - - - -



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com